Journal
BIOLOGY-BASEL
Volume 8, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/biology8020037
Keywords
multiple sclerosis; mitochondria; neuroinflammation; neurodegeneration
Categories
Funding
- North American Mitochondrial Disease Consortium (NAMDC) - National Institute of Health (NIH) U54 grant [NS078059]
Ask authors/readers for more resources
In recent years, several studies have examined the potential associations between mitochondrial dysfunction and neurodegenerative diseases such as multiple sclerosis (MS), Parkinson's disease and Alzheimer's disease. In MS, neurological disability results from inflammation, demyelination, and ultimately, axonal damage within the central nervous system. The sustained inflammatory phase of the disease leads to ion channel changes and chronic oxidative stress. Several independent investigations have demonstrated mitochondrial respiratory chain deficiency in MS, as well as abnormalities in mitochondrial transport. These processes create an energy imbalance and contribute to a parallel process of progressive neurodegeneration and irreversible disability. The potential roles of mitochondria in neurodegeneration are reviewed. An overview of mitochondrial diseases that may overlap with MS are also discussed, as well as possible therapeutic targets for the treatment of MS and other neurodegenerative conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available